These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 33289178)

  • 81. Physiologically based pharmacokinetic modeling of (18)F-SiFAlin-Asp3-PEG1-TATE in AR42J tumor bearing mice.
    Maaß C; Rivas JR; Attarwala AA; Hardiansyah D; Niedermoser S; Litau S; Wängler C; Wängler B; Glatting G
    Nucl Med Biol; 2016 Apr; 43(4):243-6. PubMed ID: 27067044
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Impact of Ethnicity-Specific Hepatic Microsomal Scaling Factor, Liver Weight, and Cytochrome P450 (CYP) 1A2 Content on Physiologically Based Prediction of CYP1A2-Mediated Pharmacokinetics in Young and Elderly Chinese Adults.
    Li GF; Zheng QS; Yu Y; Zhong W; Zhou HH; Qiu F; Wang G; Yu G; Derendorf H
    Clin Pharmacokinet; 2019 Jul; 58(7):927-941. PubMed ID: 30767128
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Physiologically Based Pharmacokinetic (PBPK) Modeling and Simulation Approaches: A Systematic Review of Published Models, Applications, and Model Verification.
    Sager JE; Yu J; Ragueneau-Majlessi I; Isoherranen N
    Drug Metab Dispos; 2015 Nov; 43(11):1823-37. PubMed ID: 26296709
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Physiological-based pharmacokinetic modeling trends in pharmaceutical drug development over the last 20-years; in-depth analysis of applications, organizations, and platforms.
    El-Khateeb E; Burkhill S; Murby S; Amirat H; Rostami-Hodjegan A; Ahmad A
    Biopharm Drug Dispos; 2021 Apr; 42(4):107-117. PubMed ID: 33325034
    [TBL] [Abstract][Full Text] [Related]  

  • 85. PBPK Modeling on Organs-on-Chips: An Overview of Recent Advancements.
    Yang Y; Chen Y; Wang L; Xu S; Fang G; Guo X; Chen Z; Gu Z
    Front Bioeng Biotechnol; 2022; 10():900481. PubMed ID: 35497341
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Sampling Site Has a Critical Impact on Physiologically Based Pharmacokinetic Modeling.
    Huang W; Isoherranen N
    J Pharmacol Exp Ther; 2020 Jan; 372(1):30-45. PubMed ID: 31604807
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Comparison of the predictive accuracy of the physiologically based pharmacokinetic (PBPK) model and population pharmacokinetic (PPK) model of vancomycin in Japanese patients with MRSA infection.
    Maruyama T; Kimura T; Ebihara F; Kasai H; Matsunaga N; Hamada Y
    J Infect Chemother; 2023 Dec; 29(12):1152-1159. PubMed ID: 37673298
    [TBL] [Abstract][Full Text] [Related]  

  • 88. A physiologically based pharmacokinetic model for chickens exposed to feed supplemented with monensin during their lifetime.
    Henri J; Carrez R; Méda B; Laurentie M; Sanders P
    J Vet Pharmacol Ther; 2017 Aug; 40(4):370-382. PubMed ID: 27943298
    [TBL] [Abstract][Full Text] [Related]  

  • 89. PKQuest_Java: free, interactive physiologically based pharmacokinetic software package and tutorial.
    Levitt DG
    BMC Res Notes; 2009 Aug; 2():158. PubMed ID: 19656378
    [TBL] [Abstract][Full Text] [Related]  

  • 90. A whole-body physiologically based pharmacokinetic (WB-PBPK) model of ciprofloxacin: a step towards predicting bacterial killing at sites of infection.
    Sadiq MW; Nielsen EI; Khachman D; Conil JM; Georges B; Houin G; Laffont CM; Karlsson MO; Friberg LE
    J Pharmacokinet Pharmacodyn; 2017 Apr; 44(2):69-79. PubMed ID: 27578330
    [TBL] [Abstract][Full Text] [Related]  

  • 91. A physiologically based pharmacokinetic drug-disease model to predict carvedilol exposure in adult and paediatric heart failure patients by incorporating pathophysiological changes in hepatic and renal blood flows.
    Rasool MF; Khalil F; Läer S
    Clin Pharmacokinet; 2015 Sep; 54(9):943-62. PubMed ID: 25773479
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Plasma, liver, and kidney exposures in rats after oral doses of industrial chemicals predicted using physiologically based pharmacokinetic models: A case study of perfluorooctane sulfonic acid.
    Kamiya Y; Yanagi M; Hina S; Shigeta K; Miura T; Yamazaki H
    J Toxicol Sci; 2020; 45(12):763-767. PubMed ID: 33268676
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Constraint-based perturbation analysis with cluster Newton method: a case study of personalized parameter estimations with irinotecan whole-body physiologically based pharmacokinetic model.
    Asami S; Kiga D; Konagaya A
    BMC Syst Biol; 2017 Dec; 11(Suppl 7):129. PubMed ID: 29322928
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Estimating meat withdrawal times in pigs exposed to melamine contaminated feed using a physiologically based pharmacokinetic model.
    Buur JL; Baynes RE; Riviere JE
    Regul Toxicol Pharmacol; 2008 Aug; 51(3):324-31. PubMed ID: 18572294
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Incorporation of the glutathione conjugation pathway in an updated physiologically-based pharmacokinetic model for perchloroethylene in mice.
    Dalaijamts C; Cichocki JA; Luo YS; Rusyn I; Chiu WA
    Toxicol Appl Pharmacol; 2018 Aug; 352():142-152. PubMed ID: 29857080
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Mechanistic prediction of food effects for Compound A tablet using PBPK model.
    Li X; Shi L; Tang X; Wang Q; Zhou L; Song W; Feng Z; Ge J; Li JK; Yang L; Wen A; Zhang Y
    Saudi J Biol Sci; 2017 Mar; 24(3):603-609. PubMed ID: 28386186
    [TBL] [Abstract][Full Text] [Related]  

  • 97. In-Depth Analysis of Physiologically Based Pharmacokinetic (PBPK) Modeling Utilization in Different Application Fields Using Text Mining Tools.
    Krstevska A; Đuriš J; Ibrić S; Cvijić S
    Pharmaceutics; 2022 Dec; 15(1):. PubMed ID: 36678737
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Risk Assessment of Perfluorooctane Sulfonate (PFOS) using Dynamic Age Dependent Physiologically based Pharmacokinetic Model (PBPK) across Human Lifetime.
    Deepika D; Sharma RP; Schuhmacher M; Kumar V
    Environ Res; 2021 Aug; 199():111287. PubMed ID: 34000270
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Physiological parameter values for physiologically based pharmacokinetic models in food-producing animals. Part III: Sheep and goat.
    Li M; Wang YS; Elwell-Cuddy T; Baynes RE; Tell LA; Davis JL; Maunsell FP; Riviere JE; Lin Z
    J Vet Pharmacol Ther; 2021 Jul; 44(4):456-477. PubMed ID: 33350478
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Development and Application of a Physiologically Based Pharmacokinetic Model for Diclazuril in Broiler Chickens.
    Yang F; Zhang M; Jin YG; Chen JC; Duan MH; Liu Y; Li ZE; Li XP; Yang F
    Animals (Basel); 2023 Apr; 13(9):. PubMed ID: 37174549
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.